First slide

The global automotive seating solution provider Lear Corporation, has added capacity at its AccuMED production facility in New York, the USA , which specializes in the manufacturing of medical products, to produce protective masks to combat the COVID-19 pandemic.

Donations of masks were made recently to the Detroit Medical Center, the largest health care provider in southeast Michigan, and the City of Detroit for use by the police and fire departments.

It protects hospital staff and public safety officers who go to work every day during this crisis to help others in need.

In February, Lear’s Mocksville, N.C., facility designed a facemask in response to a shortage of personal protective equipment in China. Lear then added production capacity for masks in less than 72 hours.

With cases of COVID-19 rising in other areas of the world, the operation has expanded from three production lines to seven, and now employs 200 people. Total capacity is 25,000 units per day, based on availability of raw materials.

In January 2020, Lear Corporation announced it had invested in Silicon Valley-based venture capital firm Autotech Ventures to support startups in deploying revolutionary mobility technologies.

May 2019, Lear Corporation, announced that it had signed CARMERA, a leader in real-time, high-definition maps for autonomous mobility, as a development partner in its EXO Technology Partnership Program.

About Lear Corporation
Lear Corporation, headquartered in Michigan, United States, is one of the world’s leading suppliers of automotive seating systems and electrical and electronic systems. Lear serves every major automaker in the world. The company has a diverse team of approximately 165,000 employees in 39 countries. Lear content can be found on more than 400 vehicle nameplates.

Prominent Global Investors

View all

Related News